Biocatalytic Cyclization of Geranyllinalool Using Zm-SHC Enzyme
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for an effective process to cyclize geranyllinalool, as existing methods do not efficiently utilize biocatalysts to convert this compound into its cyclized form.
Innovation Solution
A biocatalytic process using a cyclase with an amino acid sequence similar to Zm-SHC or its functional equivalents, which catalyzes the cyclization of geranyllinalool to form specific ring structures, such as chromene-like compounds, with high enantiomeric purity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional biocatalysts are used for cyclizing geranyllinalool, then the cyclization reaction can proceed, but the enantiomeric purity and reaction efficiency are insufficient
Solution Approach 1:
The patent applies parameter changes by optimizing reaction conditions including temperature (20-40°C), pH (5.0-8.0), and substrate concentration (10-100 mM) to achieve both high enantiomeric purity (>90% ee) and high reaction efficiency (>80% conversion). The enzyme concentration is optimized at 0.1-10 U/mL to balance selectivity and productivity.
Solution Approach 2:
The patent uses a specifically engineered cyclase enzyme from Zymomonas mobilis as an intermediary biocatalyst that mediates the cyclization of geranyllinalool. This enzyme acts as a chiral mediator to produce compounds of formula (II) with high enantiomeric purity while maintaining high catalytic efficiency.
2Ease of manufacture
If existing cyclization methods are used, then geranyllinalool can be converted, but the process lacks industrial applicability due to low efficiency
Solution Approach 1:
The patent achieves industrial applicability by optimizing reaction parameters including temperature (20-40°C), pH (5.0-8.0), and substrate concentration (10-100 mM), which enable high conversion rates (>80%) and make the process economically viable for large-scale production of compounds of formula (II).
Solution Approach 2:
The cyclase enzyme from Zymomonas mobilis exhibits self-service characteristics by catalyzing the cyclization reaction without requiring complex co-factors or additional enzymes. The enzyme autonomously converts geranyllinalool to compounds of formula (II) with high efficiency, simplifying the manufacturing process.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The process achieves high enantiomeric excess and stereospecific cyclization of geranyllinalool, producing cyclized products with high purity and efficiency, suitable for industrial applications.
Implementation Method 1
A biocatalytic process using a cyclase with an amino acid sequence similar to Zm-SHC or its functional equivalents, which catalyzes the cyclization of geranyllinalool to form specific ring structures
Data Source
AI summary
The present invention relates to a novel process for cyclizing geranyllinalool using the squalene-hopene cyclase from Zymomonas mobilis (Zm-SHC) or a cyclase with at least 80% sequence identity to the Zm-SHC, and cyclization products obtained in this process.